FDA inspection
Mount Sinai Medical Center-IRB: FDA inspection ending Nov 18, 2025
FDA inspection 1292472 · Miami Beach, FL
Key facts
| Inspection ID | 1292472 |
|---|---|
| Firm | Mount Sinai Medical Center-IRB |
| FEI number | 1044918 |
| Address | 4300 Alton Rd |
| City | Miami Beach |
| State | FL |
| ZIP | 33140-2948 |
| Fiscal year | 2026 |
| Inspection end date | Nov 18, 2025 |
| Project area | Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices |
| Product type | Biologics, Devices, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data